Patent application

Poda Provides Update on its Patent Developments Over the Past Six Years

Retrieved on: 
Wednesday, May 26, 2021
Patent law, Poda, Patent application, Patent

VANCOUVER, BC, May 26, 2021 /PRNewswire/ - PODA LIFESTYLE AND WELLNESS LTD. ("Poda Lifestyle" or the "Company") (CSE: PODA) (FSE: 99L) is pleased to announce a comprehensive update on its patent developments that have been underway for the past six years.

Key Points: 
  • VANCOUVER, BC, May 26, 2021 /PRNewswire/ - PODA LIFESTYLE AND WELLNESS LTD. ("Poda Lifestyle" or the "Company") (CSE: PODA) (FSE: 99L) is pleased to announce a comprehensive update on its patent developments that have been underway for the past six years.
  • This patent provides PODA with protection based on the patent filings allowing PODA to be the only closed ended cigarette on the market.
  • In Summary PODA has filed numerous patents under PCT as follows:
    PCT WO 2018/165769 A1 Closed Bottom Vaporizer Pod Filed September 20, 2018.
  • Poda Lifestyle's HNB system is fully patented in Canada and is patent pending in 65 additional countries, covering over 70% of the global population.

Poda Provides Update on its Patent Developments Over the Past Six Years

Retrieved on: 
Wednesday, May 26, 2021
Poda, Patent application

VANCOUVER, BC, May 26, 2021 /PRNewswire/ -- PODA LIFESTYLE AND WELLNESS LTD. ("Poda Lifestyle" or the "Company") (CSE: PODA) (FSE: 99L) is pleased to announce a comprehensive update on its patent developments that have been underway for the past six years.

Key Points: 
  • VANCOUVER, BC, May 26, 2021 /PRNewswire/ -- PODA LIFESTYLE AND WELLNESS LTD. ("Poda Lifestyle" or the "Company") (CSE: PODA) (FSE: 99L) is pleased to announce a comprehensive update on its patent developments that have been underway for the past six years.
  • This patent provides PODA with protection based on the patent filings allowing PODA to be the only closed ended cigarette on the market.
  • In Summary PODA has filed numerous patents under PCT as follows:
    PCT WO 2018/165769 A1 Closed Bottom Vaporizer Pod Filed September 20, 2018.
  • CONTACT: Poda Lifestyle and Wellness Ltd., Toll-free North America: +1-833-TRY-PODA (879-7632), Outside North America: +1-406-TRY-PODA (879-7632), [email protected] , www.podalifestyle.com

10x Genomics to Participate in Upcoming June Investor Conferences

Retrieved on: 
Monday, May 24, 2021
Monopoly, Financial markets, Patent law, 10x Genomics, United States securities law, U.S. Securities and Exchange Commission, Articles, Patent application, Patent, Regulation Fair Disclosure, Insider trading, Finance

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health.

Key Points: 
  • 10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health.
  • The companys integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology.
  • The companys patent portfolio comprises 1,100 issued patents and patent applications.
  • 10x Genomics uses filings with the Securities and Exchange Commission, its website ( www.10xgenomics.com ), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Pacira BioSciences Announces Notice of Allowance of New Patent for EXPAREL

Retrieved on: 
Tuesday, May 18, 2021
Intellectual property law, Patent law, United States Patent and Trademark Office, Patent application, Patent, Term of patent

The allowed application, \xe2\x80\x9cManufacturing of Bupivacaine Multivesicular Liposomes\xe2\x80\x9d claims composition of EXPAREL prepared by the company\xe2\x80\x99s 200-liter commercial-scale manufacturing process.

Key Points: 
  • The allowed application, \xe2\x80\x9cManufacturing of Bupivacaine Multivesicular Liposomes\xe2\x80\x9d claims composition of EXPAREL prepared by the company\xe2\x80\x99s 200-liter commercial-scale manufacturing process.
  • A Notice of Allowance is issued after the USPTO determines that the prosecution on the merits of a patent has been completed.
  • The USPTO then grants the patent upon payment of the patent issuance fee.
  • \xe2\x80\x9cThe comprehensive nature of the allowed claims underscores the deep multivesicular liposome manufacturing expertise that Pacira has accumulated over more than 25 years.

GBT Filed Patent Application for Integrated Circuit Reliability Verification Analysis

Retrieved on: 
Tuesday, May 11, 2021
Technology, Science and technology, Design for X, Materials science, Reliability engineering, Software quality, Survival analysis, Inventions, Integrated circuit, Microchip implant, Patent application, Microchip Technology

b'SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK:\xc2\xa0GTCH ) ("GBT\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), filed with the UNITED STATES PATENT AND TRADEMARK OFFICE (\xe2\x80\x9cUSPTO\xe2\x80\x9d)_ a patent application covering Integrated Circuits reliability verification analysis.

Key Points: 
  • b'SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK:\xc2\xa0GTCH ) ("GBT\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), filed with the UNITED STATES PATENT AND TRADEMARK OFFICE (\xe2\x80\x9cUSPTO\xe2\x80\x9d)_ a patent application covering Integrated Circuits reliability verification analysis.
  • The technology underlying the patent is targeted to enhance design team productivity and microchip performance for custom and synthesized ICs by enabling testing and improving/correcting of reliability issues to avoid failures.
  • Microchip\xe2\x80\x99s reliability models are based on physics-of-failure mechanisms and as manufacturing processes goes smaller electrical issues significantly rise.
  • The filed patent describes a real time method to analyze this wire early during the chip\xe2\x80\x99s design stage, and alerting the designer to make it wider.

Cannabics Pharmaceuticals Receives Patent "Notice of Allowance" From The Mexican Patent and Trademark Office (IMPI)

Retrieved on: 
Thursday, May 6, 2021
Intellectual property law, European Patent Organisation, Patent law, European Patent Office, Patent application, Patent, Outline of patents, Patent prosecution

The decision of the Mexican patent authority follows the European Patent Office (EPO) "Intention to Grant a European Patent"notice to the company from October 2020, concerning the same patent application.\nEyal Barad, Cannabics Pharmaceuticals\' co-founder and CEO commented: "This patent application is a great example of Cannabics\'s innovative and novel approach to the drug discovery process in our field.

Key Points: 
  • The decision of the Mexican patent authority follows the European Patent Office (EPO) "Intention to Grant a European Patent"notice to the company from October 2020, concerning the same patent application.\nEyal Barad, Cannabics Pharmaceuticals\' co-founder and CEO commented: "This patent application is a great example of Cannabics\'s innovative and novel approach to the drug discovery process in our field.
  • The patent was already granted in Israel and in South Africa, and we have been notified of intention to grant in Europe and now also in Mexico.
  • This opens many interesting opportunities for the company in these markets, which we intend to develop and grow.
  • We undertake no duty to update any forward-looking statement or any information contained in this press release or other public disclosures at any time.

Beyond Tobacco™ Patent Filing Advanced to Nonprovisional Status with Enhanced Scope of Protection

Retrieved on: 
Wednesday, May 5, 2021
Entheogens, Leaves, Native American religion, Tobacco, Patent application, Patent, Psychoactive drugs, Branches of biology

TAAT\xe2\x84\xa2\'s base material is Beyond Tobacco\xe2\x84\xa2, a proprietary blend which undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco.

Key Points: 
  • TAAT\xe2\x84\xa2\'s base material is Beyond Tobacco\xe2\x84\xa2, a proprietary blend which undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco.
  • Forward-looking information in this news release includes statements regarding the anticipated performance of TAAT\xe2\x84\xa2 in the tobacco industry, in addition to the following: Potential outcomes from the Company\xe2\x80\x99s recent nonprovisional patent filing in the United States.
  • As each individual is different, the benefits, if any, of taking the Company\xe2\x80\x99s products will vary from person to person.
  • No claims or guarantees can be made as to the effects of the Company\xe2\x80\x99s products on an individual\xe2\x80\x99s health and well-being.

Affinor Growers Files for Patent Protection in Eleven Additional Countries

Retrieved on: 
Saturday, May 1, 2021
Countries, Government, Foreign relations, Patent application, Patent, European Patent Convention

b'VANCOUVER, British Columbia, May 01, 2021 (GLOBE NEWSWIRE) -- Affinor Growers Inc. (\xe2\x80\x9cAffinor\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) (CSE: AFI; OTCQB: RSSFF) is pleased to announce it has filed for patent protection in eleven additional countries.\nUnited Arab Emirates Patent Application No.

Key Points: 
  • b'VANCOUVER, British Columbia, May 01, 2021 (GLOBE NEWSWIRE) -- Affinor Growers Inc. (\xe2\x80\x9cAffinor\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) (CSE: AFI; OTCQB: RSSFF) is pleased to announce it has filed for patent protection in eleven additional countries.\nUnited Arab Emirates Patent Application No.
  • PCT/CA2019/051145\nEuropean Patent Office Patent Application No.
  • This is especially important as Affinor gets ready to launch its state of the art, patented, automated, commercial vertical farm showcase in Abbotsford BC.
  • Affinor is focused on developing vertical farming technologies and using those technologies to grow fruits, vegetables, and cannabis in a sustainable manner.\nTo learn more about Affinor, visit: https://www.affinorgrowers.com/\nOn behalf of the Board of Directors,\n'

Lobe Sciences Announces Filing of PCT Application

Retrieved on: 
Thursday, April 29, 2021
Countries, Government, Foreign relations, United States patent law, Patent law, International Searching and Preliminary Examining Authorities, Patent offices, Patent application, Provisional application, Patent, United States Patent and Trademark Office, Post-traumatic stress disorder

PCT filing further strengthens the Company's intellectual property portfolio

Key Points: 
  • "\nThe Company\'s PCT filing includes details that were previously submitted in three separate US provisional patent applications filed with the U.S. Patent and Trademark Office ("USPTO").
  • The PCT is an international patent law treaty which provides a unified procedures for filing patent application to protection inventions in each of its member states.
  • By filing one international patent application under the PCT, the Company can simultaneously seek protection for an invention in 153 countries.\nThe PCT application relates to methods for treating or alleviating symptoms of mild traumatic brain injury ("mTBI"), post-traumatic stress disorder ("PTSD") and mTBI with PTSD via administration of a psychedelic agent in combination with N-acetylcysteine ("NAC").
  • Readers are cautioned that assumptions used in the preparation of the forward-looking statements may prove to be incorrect.

Radware and Netsync Team Up to Offer Cloud DDoS Protection Service to State, Local and Education Agencies

Retrieved on: 
Thursday, April 29, 2021
Intangible assets, Computer networking, Computer companies, Deep packet inspection, Radware, WAN optimization, Computing, Trademark, Patent application, Patent

Its award-winning solutions portfolio secures the digital experience by providing infrastructure, application, and corporate IT protection and availability services to enterprises globally.

Key Points: 
  • Its award-winning solutions portfolio secures the digital experience by providing infrastructure, application, and corporate IT protection and availability services to enterprises globally.
  • Any Radware products and solutions mentioned in this press release are protected by trademarks, patents and pending patent applications of Radware in the U.S. and other countries.
  • This list is intended to identify only certain of the principal factors that could cause actual results to differ.
  • Radware\xe2\x80\x99s public filings are available from the SEC\xe2\x80\x99s website at www.sec.gov or may be obtained on Radware\xe2\x80\x99s website at www.radware.com .\n"